1.
|
Adjei AA, Marks RS and Bonner JA: Current
guidelines for the management of small cell lung cancer. Mayo Clin
Proc. 74:809–816. 1999. View
Article : Google Scholar : PubMed/NCBI
|
2.
|
Simon GR and Wagner H: American College of
Chest Physicians. Small cell lung cancer. Chest. 123(Supp 1):
259S–271S. 2003. View Article : Google Scholar : PubMed/NCBI
|
3.
|
National Comprehensive Cancer Network:
National Comprehensive Cancer Network practice guidelines in
oncology v. 1.2007: small cell lung cancer. Available at:
http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdfuri.
Accessed January 9, 2007.
|
4.
|
Hyde L, Yee J, Wilson R and Panto ME: Cell
type and the natural history of lung cancer. JAMA. 193:52–54. 1965.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Lassen U, Osterlind K, Hansen M,
Dombernowsky P, Bergman B and Hansen HH: Longterm survival in
small-cell lung cancer: posttreatment characteristics in patients
surviving 5 to 18+ years - an analysis of 1,714 consecutive
patients. J Clin Oncol. 13:1215–1220. 1995.PubMed/NCBI
|
6.
|
Rawson NS and Peto J: An overview of
prognostic factors in small cell lung cancer. A report from the
Subcommittee for the Management of Lung Cancer of the United
Kingdom Coordinating Committee on Cancer Research. Br J Cancer.
61:597–604. 1990. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Knez L, Sodja E, Kern I, Košnik M and
Cufer T: Predictive value of multidrug resistance protein,
topoisomerases II and ERCC1 in small cell lung cancer: a systematic
review. Lung Cancer. 72:271–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Kin YH, Ishii G, Goto K, Ota S, Kubota K,
Murata Y, Mishima M, Saijo N, Nishiwaki Y and Ochiai A: Expression
of the breast cancer resistance protein is associated with a poor
clinical outcome in patients with small-cell lung cancer. Lung
Cancer. 65:105–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Ding C, Li R, Peng J, Li S and Guo Z: A
polymorphism at the miR-502 binding site in the 3′ untranslated
region of the SET8 gene is associated with the outcome of
small-cell lung cancer. Exp Ther Med. 3:689–692. 2012.
|
10.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11.
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Cullen BR: Transcription and processing of
human microRNA precursors. Mol Cell. 16:861–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature.
425:415–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Chendrimada TP, Gregory RI, Kumaraswamy E,
Norman J, Cooch N, Nishikura K and Shiekhattar R: TRBP recruits the
Dicer complex to Ago2 for microRNA processing and gene silencing.
Nature. 436:740–744. 2005. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: the implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Guo Z, Wu C, Wang X, Wang C, Zhang R and
Shan B: A polymorphism at the miR-502 binding site in the
3′-untranslated region of the histone methyltransferase SET8 is
associated with hepatocellular carcinoma outcome. Int J Cancer.
131:1318–1322. 2012.
|
19.
|
Campayo M, Navarro A, Viñolas N, Tejero R,
Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P,
Ramirez J and Monzo M: A dual role for KRT81: a miR-SNP associated
with recurrence in non-small-cell lung cancer and a novel marker of
squamous cell lung carcinoma. PLoS One. 6:e225092011. View Article : Google Scholar : PubMed/NCBI
|
20.
|
de Larrea CF, Navarro A, Tejero R, Tovar
N, Díaz T, Cibeira MT, Rosiñol L, Ferrer G, Rovira M, Rozman M,
Monzó M and Bladé J: Impact of MiRSNPs on survival and progression
in patients with multiple myeloma undergoing autologous stem cell
transplantation. Clin Cancer Res. 18:3697–3704. 2012.PubMed/NCBI
|
21.
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer
Institute of the United States, National Cancer Institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar
|
22.
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
24.
|
Melo SA, Moutinho C, Ropero S, Calin GA,
Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya
G, Yamamoto H, Schwartz S Jr and Esteller M: A genetic defect in
exportin-5 traps precursor microRNAs in the nucleus of cancer
cells. Cancer Cell. 18:303–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
25.
|
Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani
JA and Wu X: Genetic variations in microRNA-related genes are novel
susceptibility loci for esophageal cancer risk. Cancer Prev Res
(Phila). 1:460–469. 2008. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I,
Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene
expression deregulation in human breast cancer. Cancer Res.
65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|